Literature DB >> 8896536

Varicella: historical perspective and clinical overview.

T H Weller1.   

Abstract

In immunocompetent children in Europe and the United States, varicella is usually a benign disease. However, infants born to women who acquire varicella during or shortly after pregnancy are at high risk of infection. For unknown reasons, the disease is more severe in adolescents and adults, with pneumonia the most common cause of death. Varicella may also be lethal in patients of any age in the presence of biologic or iatrogenic immunosuppression. It is now well documented that varicella-zoster virus remains latent in the dorsal root and cranial ganglia following an attack of varicella. Viral reactivation appears with advancing age as cellular immunity wanes. The contemporary relative aging of the population will enhance the social significance of zoster. The immigration of nonimmune adults in temperate climates poses a major problem in terms of protection of high-risk children. A vaccination program is indicated.

Entities:  

Mesh:

Year:  1996        PMID: 8896536     DOI: 10.1093/infdis/174.supplement_3.s306

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirus.

Authors:  Eric J Yager; In-Jeong Kim; Michael L Freeman; Kathleen G Lanzer; Claire E Burkum; Tres Cookenham; David L Woodland; Marcia A Blackman
Journal:  Immun Ageing       Date:  2010-02-02       Impact factor: 6.400

2.  Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.

Authors:  Stefan L Oliver; Marvin H Sommer; Mike Reichelt; Jaya Rajamani; Leonssia Vlaycheva-Beisheim; Shaye Stamatis; Jason Cheng; Carol Jones; James Zehnder; Ann M Arvin
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

Review 3.  Preventing varicella-zoster disease.

Authors:  Sophie Hambleton; Anne A Gershon
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 4.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

5.  Varicella susceptibility in a Canadian population.

Authors:  S Ratnam
Journal:  Can J Infect Dis       Date:  2000-09

6.  Reactogenicity to a live attenuated varicella vaccine in Canadian children.

Authors:  F Diaz-Mitoma; S A Halperin; D Scheifele
Journal:  Can J Infect Dis       Date:  2000-03

Review 7.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

8.  Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts.

Authors:  Tomohiko Sadaoka; Hironori Yoshii; Takayoshi Imazawa; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Characterization of the varicella-zoster virus ORF50 gene, which encodes glycoprotein M.

Authors:  Tomohiko Sadaoka; Tatsuya Yanagi; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2010-01-27       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.